Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
This study has been terminated.
Study NCT00563758   Information provided by Hospital Authority, Hong Kong
First Received: August 15, 2007   Last Updated: June 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Constipation
Chronic Disease
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
tegaserod
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Agonists
Sponsors listed in this trial
Hospital Authority, Hong Kong
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services